Clarithromycin and statin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Clarithromycin may increase simvastatin exposure and myopathy risk
Clarithromycin inhibits CYP3A4 and can markedly increase simvastatin exposure. This increases the risk of myopathy and rhabdomyolysis, particularly in older patients and those with renal impairment. The prescriber should be contacted to consider withholding simvastatin or using an alternative antibiotic. Chelation is not the relevant mechanism.
Reference: BNF